Cargando…

Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells

BACKGROUND: Endogenously produced interferons can regulate the growth of melanoma cells and are administered exogenously as therapeutic agents to patients with advanced cancer. We investigated the role of negative regulators of interferon signaling known as suppressors of cytokine signaling (SOCS) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lesinski, Gregory B, Zimmerer, Jason M, Kreiner, Melanie, Trefry, John, Bill, Matthew A, Young, Gregory S, Becknell, Brian, Carson, William E
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858748/ https://www.ncbi.nlm.nih.gov/pubmed/20398276 http://dx.doi.org/10.1186/1471-2407-10-142

Ejemplares similares

Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated with Interferon Beta or Glatiramer Acetate
por: Rojas-Morales, Emmanuel, et al.
Publicado: (2019)

Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells
por: Yang, Jennifer, et al.
Publicado: (2014)

The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity
por: Bill, Matthew A, et al.
Publicado: (2010)

PRMT5 Is Upregulated in Malignant and Metastatic Melanoma and Regulates Expression of MITF and p27(Kip1)
por: Nicholas, Courtney, et al.
Publicado: (2013)

Soy isoflavones and their metabolites modulate cytokine-induced natural killer cell function
por: Mace, Thomas A., et al.
Publicado: (2019)

Development of IFN-γ resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells
por: Fojtova, M, et al.
Publicado: (2007)

The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1
por: Mathieu, M G, et al.
Publicado: (2014)

The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma
por: Suarez, Lorena P., et al.
Publicado: (2016)

Effects of valproic acid on SOCS-1, SOCS-2, SOCS-3, SOCS-5, SOCS6, and SOCS-7 gene expression and cell growth inhibition in colon carcinoma
por: Sanaei, Masumeh, et al.
Publicado: (2022)

Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy
por: Lenci, Romina Elizabeth, et al.
Publicado: (2012)

Structurally Modified Curcumin Analogs Inhibit STAT3 Phosphorylation and Promote Apoptosis of Human Renal Cell Carcinoma and Melanoma Cell Lines
por: Bill, Matthew A., et al.
Publicado: (2012)

A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma
por: Monk, Paul, et al.
Publicado: (2014)

SOCS-1 inhibition of type I interferon restrains Staphylococcus aureus skin host defense
por: Klopfenstein, Nathan, et al.
Publicado: (2021)

Fish Suppressors of Cytokine Signaling (SOCS): Gene Discovery, Modulation of Expression and Function
por: Wang, Tiehui, et al.
Publicado: (2011)

Security operations center guidebook: a practical guide for a successful SOC
por: Jarpey, Gregory, et al.
Publicado: (2017)

LPS Regulates SOCS2 Transcription in a Type I Interferon Dependent Autocrine-Paracrine Loop
por: Hu, Jin, et al.
Publicado: (2012)

Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection
por: Wei, Haitao, et al.
Publicado: (2014)

Individual and Synergistic Anti-Coronavirus Activities of SOCS1/3 Antagonist and Interferon α1 Peptides
por: Ahmed, Chulbul M., et al.
Publicado: (2022)

Therapeutic Implication of SOCS1 Modulation in the Treatment of Autoimmunity and Cancer
por: Sharma, Jatin, et al.
Publicado: (2019)

Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma
por: Farren, Matthew R, et al.
Publicado: (2015)

Adjuvant interferon in the treatment of melanoma
por: Middleton, M R
Publicado: (1999)

Adjuvant interferon in the treatment of melanoma
por: Kirkwood, J M
Publicado: (2000)

Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm
por: Zhang, Min Yue, et al.
Publicado: (2013)

Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer
por: Letellier, E, et al.
Publicado: (2014)

Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3
por: Ventero, Maria Paz, et al.
Publicado: (2019)

Lack of association between SOCS3 and SOCS7 polymorphisms and psoriasis
por: Özçep, Merve, et al.
Publicado: (2022)

Correction: Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection
por: Wei, Haitao, et al.
Publicado: (2016)

DHAV-1 Inhibits Type I Interferon Signaling to Assist Viral Adaption by Increasing the Expression of SOCS3
por: Xie, Jinyan, et al.
Publicado: (2019)

Downregulation of SOCS1 increases interferon-induced ISGylation during differentiation of induced-pluripotent stem cells to hepatocytes
por: Edwards, Jasmine S., et al.
Publicado: (2022)

SOC for Supply Chain
por: AICPA
Publicado: (2020)

SOCS, Inflammation, and Autoimmunity
por: Yoshimura, Akihiko, et al.
Publicado: (2012)

Drosophila SOCS Proteins
por: Stec, Wojciech J., et al.
Publicado: (2011)

SOC functions and their applications
por: Chen, Jein-Shan
Publicado: (2019)

SOCS, inflammation, and cancer
por: Inagaki-Ohara, Kyoko, et al.
Publicado: (2013)

Correction: Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3
por: Ventero, Maria Paz, et al.
Publicado: (2019)

Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma
por: García-Ortega, María Belén, et al.
Publicado: (2023)

HTLV-1 Evades Type I Interferon Antiviral Signaling by Inducing the Suppressor of Cytokine Signaling 1 (SOCS1)
por: Olière, Stéphanie, et al.
Publicado: (2010)

HTLV-1 evades Type 1 interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1)
por: Olière, Stéphanie, et al.
Publicado: (2011)

Silencing of microRNA-122 enhances interferon-α signaling in the liver through regulating SOCS3 promoter methylation
por: Yoshikawa, Takeshi, et al.
Publicado: (2012)

Adjuvant interferon in melanoma – a resurrection?
por: Middleton, M R, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_jsuoqi87pm6fnft6ohkdfmipc4